New cancer clinical trial: 9-ING-41 in Patients With Advanced Cancers

Published on: September 20, 2018 at 12:00PM
Condition:   Cancer
Interventions:   Drug: 9-ING-41;   Drug: Gemcitabine - 21 day cycle;   Drug: Doxorubicin.;   Drug: Lomustine;   Drug: Carboplatin.;   Drug: Nab paclitaxel.;   Drug: Paclitaxel.;   Drug: Gemcitabine - 28 day cycle
Sponsors:   Actuate Therapeutics Inc.;   Developmental Therapeutics Consortium
Not yet recruiting
https://ift.tt/2xD15og